Top Clinical Trials companies in Denmark by Revenue
This ranking features the top 5 Clinical Trials companies in Denmark ranked by Revenue, totalling a Revenue of USD 2.44 B, for January 15, 2025.
Denmark
Clinical Trials
Revenue
# |
Name |
Revenue |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
|---|---|---|---|---|---|---|---|
| 1 |
USD 2.44 B
|
Dec. 31, 2023 | USD 216.88 | 1.28% |
|
Denmark |
|
| 2 |
USD 1.66 M
|
Dec. 31, 2023 | USD 0.57 | 1.47% |
|
Denmark |
|
| 3 |
USD 1.03 M
|
Dec. 31, 2023 | USD 1.93 | -6.19% |
|
Denmark |
|
| 4 |
USD 62.61 K
|
Dec. 31, 2023 | USD 3.98 | 0.01% |
|
Denmark |
|
| 5 |
USD 0.00
|
Dec. 31, 2023 | USD 0.64 | 1.38% |
|
Denmark |
Frequently Asked Questions
-
Which Clinical Trials company in Denmark has the highest Revenue ?
The Clinical Trials company in Denmark with the highest Revenue is Genmab A/S (Copenhagen Stock Exchange: GMAB.CO) at USD 2.44 B.
-
Which Clinical Trials company in Denmark has the lowest Revenue ?
The Clinical Trials company in Denmark with the lowest Revenue is Initiator Pharma A/S (Stockholm Stock Exchange: INIT.ST) at USD 0.00.
-
What are the top 10 Clinical Trials companies in Denmark by Revenue ?
The top 10 Clinical Trials companies in Denmark by Revenue are Genmab A/S, Saniona AB (publ), ViroGates A/S, FluoGuide A/S and Initiator Pharma A/S.
-
What are the bottom 10 Clinical Trials companies in Denmark by Revenue ?
The bottom 10 Clinical Trials companies in Denmark by Revenue are Initiator Pharma A/S, FluoGuide A/S, ViroGates A/S, Saniona AB (publ) and Genmab A/S.